SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Northwest Biotherapeutics Inc.
NWBO 0.240+3.6%3:54 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Gary Mohilner8/21/2022 2:03:01 PM
   of 759
 
I believe that things are rapidly coming to a head with NWBO. There is good reason to believe that they've filed for approval in the U.K. The reason is that they've filed for approval of their commercial manufacturing facility a few months ago and normally you file for approval shortly after that. I believe they'll announce when that filing has been accepted.

No one knows when the Journal they're expecting will happen, but they're very committed to it. They've clearly delayed calling an Annual Meeting but at some point it must happen, even if they're still in a quiet period because of terms of the embargo they agreed on in the Journal submission. The presentations recently clearly don't contain the full trial data, they're material permitted to be released by the sequester.

While what's revealed indicates the vaccine more than doubles the odds of long term survival for GBM patients, I believe what will be revealed in the Journal will be substantially more powerful as things like the previously revealed data for the Top 100 survivors in the trial cannot be seen in the data released to date.

In short, there is a lot of good information to come and I believe it will be followed by approvals by all four of the regulators by mid-2023.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News